Bio Green Med Solution (BGMS) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 6.48% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | -6.81% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 92.37% |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 5.21% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 151.28% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 327.74% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | -12.04% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 95.87% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 68.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.24% |
| Mar 31, 2026 | -167.90% |
| Dec 31, 2025 | -233.22% |
| Sep 30, 2025 | -27.90% |
| Jun 30, 2025 | 58.92% |
| Mar 31, 2025 | 97.25% |
| Dec 31, 2024 | 42.64% |
| Sep 30, 2024 | 67.82% |
| Jun 30, 2024 | 40.76% |
| Mar 31, 2024 | 49.68% |
| Dec 31, 2023 | 28.76% |
| Sep 30, 2023 | -15.89% |
| Jun 30, 2023 | -18.88% |
| Mar 31, 2023 | -40.79% |
| Dec 31, 2022 | -181.80% |
| Sep 30, 2022 | 21.38% |
| Jun 30, 2022 | 10.66% |
| Mar 31, 2022 | -17.86% |
| Dec 31, 2021 | 345.00% |
| Sep 30, 2021 | -189.46% |